PGEN trade ideas
PGENBiotech sector needs some love, this stock right here has had significant insider buying within the last 3 months. Although the right idea is to wait for profitability, regular investors should keep an eye on this t enter a long position if the price were to drop to $ 1.33 USD again in value. Anything less id be adding even more as I see potential LONG term see some potential as a short term swing.
its its going to break out past 1.43 that would be great very soon.
good luck
Precigen Announces Clearance of IND to Initiate Phase 1/1b StudyPGEN: Precigen, Inc.
2021-10-26 08:05:00
Precigen Announces Clearance of IND to Initiate Phase 1/1b Study for PRGN-3007 UltraCAR-T® in Advanced ROR1+ Hematological and Solid Tumors
PGEN earnings beat, 9 breakout of daily flagPGEN is a pretty beaten up stock, had a recent surprise ER and looking over the past it performs decent in the days following a beat. As well a long daily flag has been created and was broken on a Friday of last week. The continuation did not hold on Friday but it was Friday and they suck for breakout confirmations. Watching close over 9 for a pop to 10. If can close above 10 will hold a few shares for a swing with an 11 target
paytience will payout here small downtrend channel here, should head back to 11 once it breaks though. the question is will it break and when? I wouldn't get in unless we see confirmation, for now its possible we see a dip to 7 before running back to 11+ be paytient! and goodluck :)
$PGEN slightly used , but profitable having a single day without looking on charts is a waste of your time and money ..
Precigen, Inc On watch-list Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. The firm focuses on programming biological systems to alleviate disease, remediate environmental challenges, and provide sustainable food and industrial chemicals. It operates through the following segments: PGEN Therapeutics, ActoBio, MBP Titan, Trans Ova and All Other. The PGEN Therapeutics segment is advancing the next generation of gene and cell therapies using precision technology to target urgent and intractable diseases in immuno-oncology, autoimmune disorders and infectious diseases. The ActoBio segment involves in pioneering a proprietary class of microbe-based biopharmaceuticals that enable expression and local delivery of disease-modifying therapeutics. The MBP Titan segment comprises of Methane Bioconversion Platform, and associated technologies, personnel, and facilities The Trans Ova segment includes provides advanced reproductive technologies. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.
PGEN target - mid 8'sSee chart - i am in PGEN as of today - 8/21 $7.5 calls.
We have broken two trendlines and also two fib levels to the upside
